Kuopion yliopistollinen sairaala
Kuopio University Hospital

Julkaisut 2004
Publications 2004

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Farge D et al. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry.
2 Snowden JA et al. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR .
3 Aaltomaa S et al. The expression and prognostic value of alfa-, beeta- and gamma-catenins in renal cell carcinoma.
4 Aburawi E et al. Acute respiratory viral infections aggravate arterial endothelial dysfunction in children with type 1 diabetes.
5 Ahonen J. Onko lääkkeen imeytymisvaiheen yhteisvaikutuksilla käytännön merkitystä?
6 Ahonen J. Suojaavatko maitohappobakteerit antibioottikuurin aiheuttamalta ripulilta?
7 Aira M, Tacke U. Kuopion yliopistollisen sairaalan huume- ja lääkeriippuvuuspoliklinikan toiminta.
8 Airaksinen KEJ et al. Diabetes and haemodynamic reactions to acute coronary occlusion.
9 Airenne KJ et al. Baculovirus-mediated gene transfer: An evolving new concept.
10 Ajamian F et al. Selective regulation of class I and class II histone deacetylases expression by inhibitors of histone deacetylases in cultured mouse neural cells.
11 Alhava E. Osteoporoosin epidemiologia Suomessa.
12 Andrulionyte L et al. Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial.
13 Antikainen R et al. A decrease in memory complaints in associated with mood improvement: A twelve-month follow up-study of depressed patients.
14 Anttila T et al. Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study.
15 Arikoski P et al. Intravenous pamidronate treatment in children with moderate to severe osteogenesis imperfecta: assessment of indices of dual-energy X-ray absorptiometry and bone metabolic markers during the first year of therapy.
16 Arokoski JP et al. Activation of lumbar paraspinal and abdominal muscles during therapeutic exercises in chronic low back pain patients.
17 Arokoski JPA. Nivelrikko - sairauden syyt ja hoidon mahdollisuudet.
18 Arokoski JPA et al. Estimation of femoral head bone density using magnetic resonance imaging.
19 Arokoski JPA et al. Polvi- ja lonkkanivelrikon konservatiinen lääkkeetön hoito.
20 Arokoski MH et al. Physical function in men with and without hip osteoarthritis.
21 Astuti D et al. Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma.
22 Aukee P et al. The effect of home biofeedback training on stress incontinence.
23 Autere J et al. Mitochondrial DNA polymorphisms as risk factors for Parkinson´s disease and Parkinson´s disease dementia.
24 Autio K et al. Starch in food diabetes and coronary heart disease.
25 Auvinen A et al. A randomized trial of choice of treatment in prostate cancer: the effect of intervention on the treatment chosen.
26 Banning A et al. Inhibition of basal and interleukin-1-induced VCAM-1 expression by phospholipid hydroperoxide glutathione peroxidase and 15-lipoxygenase in rabbit aortic smooth muscle cells.
27 Barnett AH et al. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabtes and nephropathy.
28 Bartnik M et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart.
29 Bhowmik A et al. Regulation of restitution after superficial injury in isolated guinea pig gastric mucosa.
30 Biard J-M et al. Pulmonary effects of gastroschisis in a fetal rabbit model.
31 Blomstedt G, Jääskeläinen J. Keskushermoston infektiot.
32 Blomstedt G et al. Funktionaalinen neurokirurgia.
33 Boccardi M et al. APOE and modulation of Alzheimer´s and frontotemporal dementia.
34 Boden G, Laakso M. Lipids and glucose in type 2 diabetes: what is the cause and effect?
35 Bonetti A et al. A two-stage study on multiple sclerosis susceptibility and chromosome 2q33.
36 Brainin M et al. Organization of stroke care: education, referral, emergency management and imaging, stroke units and rehabilitation.
37 Böhm J et al. Duodenumin fisteli - kavala kirurginen komplikaatio.
38 Casas KA et al. Chromosome 2q terminal deletion: Report of 6 new patients and review of phenotype-breakpoint correlations in 66 individuals.
39 Charbonnel B et al. The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients.
40 Chiasson J-L et al. Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data.
41 Cuesta-Munoz AL et al. Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation.
42 D'Agostino Jr RB et al. Cardiovascular disease risk factors predict the development of type 2 diabetes. The Insulin resistance atherosclerosis study.
43 Diener H-C et al. Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischaemic attack of ischaemic stroke (MATCH): Study design and baseline data.
44 Diener H-C et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial.
45 Echeverria V et al. Rat transgenic models with a phenotype of intracellular Abeta accumulation in hippocampus and cortex.
46 Echeverria V et al. Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the beta-amyloid peptide intracellularly in hippocampal and cortical neurons.
47 Eeva J, Pelkonen J. Mechanisms of B cell receptor induced apoptosis.
48 Ervasti M et al. In patients who have stainable iron in the bone marrow an elevated plasma transferrin receptor value may reflect functional iron deficiency.
49 Eskelinen M et al. Preoperative serum levels of follicle stimulating hormone (FSH) and prognosis in invasive breast cancer.
50 Faisel F et al. Susceptibility to pre-eclampsia in Finnish women is associated with R485K polymorphism in the factor V gene, not with Leiden mutation.
51 Forss H, Widström E. Reasons for restorative therapy and the longevity of restorations in adults.
52 Friedlich AL et al. Neuronal zinc exhange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer´s disease.
53 Frösen J et al. Remodeling of saccular cerebral artery aneurysm wall is associated with rupture.Histological analysis of 24 unruptured and 42 ruptured cases.
54 Girman CJ et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
55 Grigorenko NA et al. A new synthesis of alfa-methylspermidine.
56 Gruchala M et al. Gene transfer into rabbit arteries with adeno-associated virus and adenovirus vectors.
57 Gruchala M et al. Gene therapy for cardiovascular diseases.
58 Gulbinowicz M et al. Morphometric analysis of the small intestine in wild type mice C57BL/6J - a developmental study.
59 Gureviciene I et al. Normal induction by accelerated decay of LTP in APP + PS1 transgenic mice.
60 Gurevicius K et al. Enhanced cortical and hippocampal neuronal excitability in mice deficient in the extracellular matrix glycoprotein tenascin-R.
61 Gylling H. Kommentteja Antti Heikkilän väittämiin ravitsemuksesta.
62 Gylling H. Cholesterol metabolism and its implications for therapeutic interventions in patients with hypercholesterolaemia.
63 Gylling H et al. Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorbtion and insulin sensitivity.
64 Gylling H et al. Yksi muutos - uuden elämän alku. Laihduttamisesta painonhallintaan.
65 Gylling H, Palonen R. Lääkevahinko - mikä se on.
66 Gylling H et al. Cholesterol metabolism in type 1 diabetes.
67 Haara MM et al. Osteoarthritis in the carpometacarpal joint of the thumb. Prevalence and associations with disability and mortality.
68 Haatainen K et al. Factors associated with hopelessness: A population study.
69 Haatainen KM. Hopelessness in a General Population of Finnish Adults.
70 Haavisto A et al. Factors associated with depressive symptoms among 18-year-old boys: a prospective 10-year follow-up study.
71 Haenggi M et al. Measuring depth of sedation with auditory evoked potentials during controlled infusion of propofol and remifentanil in healthy volunteers.
72 Hakala T et al. Cardioplegic arrest does not increase the risk of atrial fibrillation after coronary artery bypass surgery.
73 Hakulinen MA et al. Ability of ultrasound backscattering to predict mechanical properties of bovine trabecular bone.
74 Halmesmäki K et al. A randomized controlled trial of hysterectomy or levonorgestrel-releasing intaruterine system in the treatment of menorrhagia-effect on FSH levels and menopausal symptoms.
75 Halonen T et al. Menetelmäperiaatteet ja kliinisen kemian tutkimukset.
76 Hanisch U-K et al. The microglia-activating potential of thrombin.
77 Hartikainen J. Sepelvaltimoiden pallolaajennushoito.
78 Hartikainen S et al. Etenkin dementoituneet käyttävät runsaasti psyykenlääkkeitä.
79 Harvima IT et al. Heparin modulates the growth and adherence and augments the gowth-inhibitory action of TNF-alpha on cultured human keratinocytes.
80 He H et al. A study on non-pharmacological treatments on children's postoperative pain relief (in Chinese).
81 He H et al. Postoperative Pain Management in Children - Emphasis on the Use of Non-pharmacological Methods (kiinankielinen).
82 Hedman A et al. Inducibility of life-threatening ventricular arrhythmias is related to maximum left ventricular thickness and clinical markers of sudden cardiac death in patients with hypertrophic cardiomyopathy attridutable to the Asp175Asn mutation in the Alfa-tropomyo.
83 Heikkilä K et al. A survey of the attitudes of infertile and parous women towards the availability of assisted reproductive technology.
84 Heikkinen A-M et al. Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women .
85 Heikkinen M et al. Prognostic significance of antrum-predominant gastritis in functional dyspepsia.
86 Heikkinen S. Glucose Metabolism in Heterozygous Hexokinase II Knock-out Mice.
87 Heikkinen T et al. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation.
88 Heikkinen T et al. Effects of long-term ovariectomy and estrogen treatment on maze learning in aged mice.
89 Heinonen S. Sikiöseulonnat lääkärin näkökulmasta.
90 Heinonen S. Gynekologit johtajakoulussa - kokemuksia erikoisalakohtaisesta hallinnon koulutuksesta.
91 Heinonen S et al. The 121Q allele of the plasma cell membrane glycoprotein 1 gene predisposes to polycystic ovary syndrome.
92 Heinonen S, Puolakka J. Raskauden jälkipuoliskon verenvuodot.
93 Heiskanen M et al. Kouluikäisten lasten leikkauksen jälkeinen kipu ja kivunhoito.
94 Helisalmi S et al. Possible association of nicastrin polymorphisms and Alzheimer disease in the Finnish population.
95 Helisalmi S et al. Genetic variation in apolipoprotein D and Alzheimer´s disease.
96 Helisalmi S et al. Polymorphisms in neprilysin gene affect the risk of Alzheimer´s disease in Finnish patients.
97 Hellsten K et al. Gammakuvauksen merkitys lisäkilpirauhasadenooman paikantamisessa.
98 Hernesniemi J, Jääskeläinen J. Aivoverisuonitaudit.
99 Herno A. Spinal stenosis without deformity: nonoperative treatment.
100 Hiitola P et al. Kliinisen farmasian kehitys ja nykytila Suomessa.
101 Hills SA et al. The EGIR-RISC Study (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives.
102 Hiltunen M et al. Alzheimerin taudin genetiikka.
103 Hintikka J et al. Alexithymia and suicidal ideation: a 12-month follow-up study in a general population.
104 Hirvonen EA et al. Thyroid storm prior to induction of anaesthesia.
105 Hirvonen R et al. Itseään viiltelevä nuori.
106 Holmberg L et al. HABITS (hormonal replacement therapy after brest cancer-is it safe?), a randomised comparison:trial stopped.
107 Holopainen K et al. Effects of vocationally oriented medical rehabilitation for aircraft maintenance personnel - a preliminary study of long-term effects with 5-year follow-up.
108 Honkalampi K et al. Lääkärien ja sairaanhoitajien työn vaatimustekijät ja työuupumus yliopistollisessa sairaalassa.
109 Honkalampi K et al. Relationships among alexithymia, adverse childhood experiences, sociodemographic variables, and actual mood disorde: a 2-year clinical follow-up study of patients with major depressive disorder.
110 Honkalampi K et al. Do stressful life-events or sociodemographic variables associate with depression and alexithymia among a general population? - A 3-year follow-up study.
111 Hu G et al. Occupational, commuting, and leisure-time physical activity in relation to total and cardiovascular mortality among Finnish subjects with type 2 diabetes.
112 Huopio J et al. Calcaneal ultrasound predicts early postmenopausal fractures as well as axial BMD. A prospective study of 422 women.
113 Hurskainen R et al. Levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of essential menorrhagia: predictors of outcome.
114 Hurskainen R et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia.
115 Husman TM, Luosujärvi RA. Reply to letter by Lange .
116 Huttunen K et al. Synergistic interaction in simultaneous exposure to Streptomyces californicus and Stachybotrys chartarum.
117 Huuskonen J et al. Regulation of microglial inflammatory response by sodium butyrate and short-chain fatty acids.
118 Hytönen VP et al. Efficient production of active chicken avidin using a bacterial signal peptide in Escherichia coli.
119 Hänninen A, Mahlamäki EK. Kliinisen hematologian tutkimukset.
120 Hänninen T, Pulliainen V. Kognitiivisten häiriöiden seulonta.
121 Hänninen T, Soininen H. Muistihäiriöt ja dementia.
122 Hänninen-Nousiainen P et al. Rintaruokinnan trendit väestön terveysseurannassa - tuloksia Terveys 2000-tutkimuksesta.
123 Ibald-Mulli A et al. Effects of particulate air pollution on blood pressure and heart rate in subjects with cardiovascular disease: A multicenter approach.
124 Ihalainen JA, Tanila H. In vivo regulation of dopamine and noradrenaline release by alpha2A-adrenoceptors in the mouse nucleus accumbens.
125 Ihalainen S et al. Lääkeinteraktiot sairaalapotilailla.
126 Ihalainen S et al. Frequency and clinical outcome of drug-drug interactions in hospitalised patients - a pilot study.
127 Iivonen S et al. Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease.
128 Ilanne-Parikka P et al. Prevalence of the metabolic syndrome and its components. Finding from a Finnish general population sample and the diabetes prevention study cohort.
129 Immonen A et al. Preoperative clinical evaluation, outline of surgical technique and outcome in termporal lobe epilepsy.
130 Immonen A et al. Akuutit aivovammat.
131 Immonen A et al. AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled stydy.
132 Immonen J et al. Bronchial reactivity in students from moisture and mold-damaged schools: Changes in relation to changes in exposure.
133 Jakovljevic D, on behalf of the FINSTROKE Register Group. Day of the week and ischemic stroke - Is it monday high or sunday low?
134 Janket S-J et al. Asymptotic dental score and prevalent coronary heart disease.
135 Jantunen E, D´Amore F. Stem cell transplantation for peripheral T-cell lymphomas .
136 Jantunen E et al. Primaarit luulymfoomat. KYS:n kokemukset 1990-2003.
137 Jantunen E et al. Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis.
138 Jantunen E et al. Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients.
139 Jantunen E et al. Autologous stem cell transplantation in patients with primary amyloidosis: a nation-wide survey.
140 Jantunen E et al. Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey.
141 Joensuu H et al. Risk for distant recurrence of breast cancer detected by mammography ccreening or other methods.
142 Johansson R. Luukasvaimet.
143 Jokinen JJ et al. Effects of coronary artery bypass related conduction defects: a 10-year follow-up study.
144 Jones RW et al. A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer´s disease.
145 Joyal CC et al. MRI volumetry of the vermis and cerebellar hemispheres in men with schizophrenia.
146 Juonala M et al. Interrelations between brachial endothelial function and carotid intima-media thickness in young adults.
147 Jutila L. Epilepsian akuuttihoito.
148 Juutilainen A et al. Gender difference in the impact of type 2 diabetes on coronary heart disease risk.
149 Jänne J et al. Genetic approaches to the cellular functions of polyamines in mammals.
150 Järvenpää T et al. Hippocampal MRI volumetry in congenitively discordant monozygotic twin pairs.
151 Jääskeläinen E et al. M385T polymorphism in the factor V gene, but not leiden mutation, is associated with placental abruption in finnish women.
152 Jääskeläinen I et al. Requirements for delivery of active antisense oligonucleotides into cells with lipid carriers.
153 Jääskeläinen J. Neurokirurgia Suomessa.
154 Jääskeläinen J. Oireista diagnoosiin.
155 Jääskeläinen J. Kallonsisäiset kasvaimet.
156 Jääskeläinen P et al. Genetics of hypertrophic cardiomyopathy in eastern Finland: few founder mutations with benign or intermediary phenotypes.
157 Kaarteenaho-Wiik R et al. Type I and III collagen protein precursors and mRNA in the developing human lunghypertension.
158 Kaasinen SK et al. Spermidine/spermine N1-acetyltransferase overexpression in mice induces hypoactivity and spatial learning impairment.
159 Kalesnykas G et al. Cholinergic neurons in the basal forebrain of aged female mice.
160 Kanerva J et al. Favorable outcome in 20-year follow-up of children with very-low-risk ALL and minimal standard therapy, with special reference to TEL-AML1 fusion.
161 Kanis A et al. A meta-analysis of previous fracture and subsequent fracture risk.
162 Kankkonen HM et al. Feline immunodeficiency virus and retrovirus-mediated adventitial ex vivo gene transfer to rabbit carotid artery using autologous vasvular smooth muscle cells.
163 Kankkonen HM et al. Long-term lowering of plasma cholesterol levels in LDL-receptor-deficient WHHL rabbits by gene therapy.
164 Kankkunen P et al. Families' and children's postoperative pain - literature review.
165 Kanninen K et al. Glycosylation changes in Alzheimer's disease as revealed by a proteomic approach.
166 Kannisto S et al. Serum dehydroepiandrosterone sulfate concentration as an indicator of adrenocortical suppression during inhaled steroid therapy in adult asthmatic patients.
167 Kanto-Ronkanen A. Nokia 6310i ja autosarja CARKit 112 mahdollistavat vaikeavammaiselle henkilölle matkapuhelimen käytön.
168 Kanto-Ronkanen A. Avoin ammattikorkeakouluopetus työelämän tiedon päivittäjänä.
169 Kanto-Ronkanen A. Selkeyttä kuntoutuspolulle - KunNet. ammattilaisten verkkopalvelu.
170 Kantola M et al. Selenium in pregnancy: is selenium an active defective ion against environmental chemical stress?
171 Karhapää P et al. Alaonttolaskimon anomalia ja laskimotromboosi nuorella miehellä.
172 Karhu J, Länsimies E. Stressi .
173 Katila M-L, Laatikainen Aino. Kliininen mikrobiologia.
174 Katila M-L et al. Atyyppisten mykobakteerien aiheuttama tautikirjo.
175 Kattainen E. Pitkittäistutkimus sepelvaltimoiden ohitusleikkaus- ja pallolaajennuspotilaiden terveyteen liittyvästä elämänlaadusta.
176 Kattainen E, Meriläinen P. NHP, RAND-36 ja 15D mittareiden psykometristen ominaisuuksien vertailu - mittarin valinnan perustelut sepelvaltimoiden ohitusleikkaus- ja pallolaajennuspotilaiden elämänlaatututkimukseen.
177 Kauppinen T et al. Nuorten kokemukset lähisuhteista ja saamastaan tuesta yläastevuosien aikana.
178 Kemppainen S, Pitkänen A. Damage to the amygdalo-hippocampal projection in temporal lobe epilepsy: A tract-tracing study in chronic epileptic rats.
179 Kerokoski P et al. Both N-methyl-D-aspartate (NMDA) and non-NMDA receptors mediate glutamate-induced cleavage of the cyclin-dependent kinase 5 (cdk5) activator p35 in cultured rat hippocampal neurons.
180 Keski-Nisula L et al. Spontaneous and stimulated interleukin-6 and tumor necrosis factor-alpha production at delivery and three months after birth.
181 Keski-Nisula L et al. Stimulated cytokine production correlates in umbilical arterial venous blood at delivery.
182 Keskikuru R et al. Radiation-induced changes in skin type I and III collagen synthesis during and after conventionally fractionated radiotherapy.
183 Ketola A et al. Osteosarcoma and chondrosarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/gangciclovir gene therapy.
184 Ketomäki A et al. Removal of intravenous intralipid in patients with familial hypercholesterolemia during inhibition of cholesterol absorption and synthesis.
185 Ketomäki A et al. Effects of plant stanol and sterol esters on serum phytosterols in a family with familial hypercholesterolemia including a homozygous subject.
186 Khurana T et al. Angiogenesis-dependent and independent phases of intimal hyperplasia.
187 Kiiveri S et al. Transcription factors GATA-4 and GATA-6 human adrenocortical tumors.
188 Kivilompolo S et al. Moniammatilliseen yhteistyöhön perustuva potilaan lääkehoidon arviointi - tapausselostus Haukiputaan terveyskeskuksen vuodeosastolla.
189 Kivinen P. Mast Cells and Epidermis in Skin Culture.
190 Kivipelto L, Jääskeläinen J. Kallonsisäinen dynamiikka.
191 Klareskog L et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
192 Koistinaho J et al. Tetracycline derivates as anti-inflammatory agents and potential agents in stroke treatment.
193 Koivisto TT et al. Primary Helicobacter pylori resistance to metronidazole and clarithromycin in the Finnish population.
194 Koivu A. Työnohjaus koulumaailmassa: yksilölliset, yhteisölliset ja rakenteelliset esteet ja mahdollisuudet.
195 Koivula I et al. Vakavat pneumokokki-infektiot ja epäonnistunut makrolidihoito.
196 Koivumaa-Honkanen H et al. Life satisfaction and depression in a 15-year follow-up of healthy adults.
197 Koivumaa-Honkanen H et al. Life dissatisfaction and subsequent work disability in an 11-year follow up.
198 Kokki H. Current management of pediatric postoperative pain.
199 Kokki H. Lääkkeiden haittavaikutukset lapsilla.
200 Kokki H et al. Ketoprofen for add-on pain treatment to paracetamol after strabismus surgery in children.
201 Kokki H et al. Pharmacokinetics of oxycodone after intravenous, buccal, intramuscular and gastric administration in children.
202 Kokki H et al. Levobupivacaine for pediatric spinal anesthesia.
203 Kokkonen A et al. Reumapotilaiden kiertäjäkalvosimen preoperatiivisen magneettikuvauslöydöksen vertaaminen leikkauslöydökseen olkapään artroplastiassa.
204 Kokkonen M et al. Toivottomuus ja omahoitajasuhde masentuneen potilaan arvioimana sairaalahoidon aikana.
205 Kokkonen M et al. A comparison of spinal anaesthesia and propofol-sevoflurane-anaesthesia for ambulatory knee arthroscopy.
206 Komulainen J et al. Lasten ja nuorten diabeteksen hyvän hoidon laatukriteerit.
207 Korhonen K et al. Do inhaled steroids differ from cromones in terms of hospital admission rates for asthma in children?
208 Korpela M et al. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study.
209 Korppi M. Non-specific host response markers in the differentation between pneumococcal and viral pneumonia: What is the most accurate combination?
210 Korppi M et al. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: Serological results of a prospective, population-based study in primary health care.
211 Korppi M et al. Rhinovirus-associated wheezing in infancy. Comparison with respiratory syncytial virus bronchiolitis.
212 Korppi M et al. Chlamydia pneumoniae and newly diagnosed asthma: a case-control study in 1 to 6-year-old children.
213 Korppi M et al. Respiratory morbidity 20 years after RSV infection in infancy.
214 Koskela HO et al. Coughing during mannitol challenge is associated with asthma.
215 Koskinen K et al. Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1).
216 Kosunen A et al. Reduced expression of hyaluronan is a strong indicator of poor survival in oral squamous cell carcinoma.
217 Kotilainen P et al. Spinaalikanavan sairaudet.
218 Koukkunen H et al. Low-risk patients with chest pain and without evidence of myocardial infarction may be safely discharged from emergency department.
219 Kröger L, Arikoski P. Lapsuusiän krooniset sairaudet ja luusto.
220 Kröger L et al. Transient bone marrow oedema in a child.
221 Kubaszek A. Plasma Cell Glycoprotein-1, Interleukin-6 and Tumor Necrosis Factor-Alfa as Candidate Genes for Insulin Resistance, Obesity and Type 2 Diabetes .
222 Kubaszek A et al. The association of the K121Q polymorphism of the plasma cell glycoprotein-1 gene with type 2 diabetes and hypertension depends on size at birth.
223 Kubová H et al. Status epilepticus in immature rats leads to behavioural and cognitive impairment and epileptogenesis.
224 Kuikka JT. Quantitative accuracy of serotonergic neurotransmission imaging with high-resolution 123I SPECT.
225 Kuittinen T et al. Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma.
226 Kuivalainen L. Eturauhassyöpää sairastavien miesten terveyteen liittyvä elämänlaatu vuoden seuranta-aikana.
227 Kumpulainen K. Lapsuuden traumaperäinen stressireaktio ja kognitiivis-behavioraalinen terapia.
228 Kumpulainen K. Epidemiologia ja häiriöiden jatkuvuus.
229 Kumpusalo E et al. Lääkärien johtamistaidot kollegoiden arvioimana.
230 Kurkijärvi JE et al. Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) and T2 characteristics of human knee articular cartilage: Topographical variation and relationships to mechanical properties.
231 Kurola J et al. Airway management in cardiac arrest - comparison of the laryngeal tube, tracheal intubation and bag-valve mask ventilation in emergency medical training.
232 Kuusela TA et al. Effects of terbutaline on peripheral vascular resistance and arte compliance.
233 Kuusisto E. Role of the p62 Protein in the Formation of Neuropathological Cytoplasmic Inclusions.
234 Kvist T. Hoidon laatu - potilaiden ja henkilöstön yhteinen asia?
235 Kyrölä K et al. Long-term MRI findings in operated rotaror cuff tear.
236 Kärkkäinen S. Genetics of Dilated Cardiomyopathy in the Eastern Finnish Population .
237 Kärkkäinen S et al. Two novel mutations in the beta-myosin heavy chain gene associated with dilated cardiomyopathy.
238 Kärkkäinen S et al. A novel mutation, Ser143Pro, in the lamin A/C gene is common in finnish patients with familial dilated cardiomyopathy.
239 Kärpänoja P et al. Disc diffusion susceptibility testing of Haemophilus influenzae by NCCLS methodology using low-strength ampicillin and co-amoxiclav discs.
240 Laakso M. The relative importance of cardiovascular risk factors in type 2 diabetic.
241 Laakso M. Gene variants, insulin resistance, and dyslipidaemia.
242 Laaksonen DE et al. Serum linoleic and total polyunsaturated fatty acids in relation to prostate and other cancers: a populationbased cohort study.
243 Laaksonen DE et al. Epidemiology and treatment of the metabolic syndrome.
244 Laaksonen DE et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men.
245 Laaksonen DE et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.
246 Laasanen J. The Search for Genes Predisposing to Preeclampsia.
247 Laasonen-Balk T et al. 123I-beta-CIT binding and recovery from depression. A six-month follow-up study.
248 Lahtinen P et al. S(+)-Ketamine as an analgesic adjunct reduces opioid consumption after cardiac surgery.
249 Laitinen T. Endoteelitoiminnan häiriö - linkki verisuonisairauksien ja metabolisten häiriöiden välillä.
250 Laitinen T et al. Age dependency of cardiovascular autonomic responses to head-up tilt in healthy subjects.
251 Laivoranta-Nyman S et al. HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis.
252 Lammi MJ et al. Hydrostatic pressure-induced changes in cellular protein syntheisis.
253 Lammi MJ et al. Undersulfated chondroitin sulfate does not increase in osteoarthritic cartilage.
254 Langley S et al. European collaborative group on prostate brachytherapy: preliminary report in 1175 patients.
255 Laukkanen JA et al. Systolic blood pressure during recovery from exercise and the risk of acute myocardial infarction in middle-aged men.
256 Laukkanen JA et al. The predictive value of cardiorespiratory fitness for cardiovascular events in men with various risk profiles: a prospective population-based cohort study.
257 Laukkanen JA et al. Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study.
258 Laukkanen O et al. Common polymorphisms in the genes regulating the early insulin signalling pathway: effects on weight change and the conversion from impaired glucose tolerance to Type 2 diabetes.
259 Laukkanen O et al. Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish diabetes prevention study.
260 Laukkanen T, Laukkanen E. Sijaislapsista suuri osa vailla tarvitsemaansa psykiatrista apua.
261 Laurema A et al. Fetal membranes act as a barrier for adenoviruses: gene transfer into exocoelomic cavity of rat features does not affect cells in the fetus.
262 Lehto S, Kurola J. Elinluovutukset KYSissä 2002.
263 Lehtonen A et al. Declining incidence and mortality of stroke in persons aged > or = 75 years in Finland; the FINSTROKE study.
264 Lehtonen J. Descartes' cogito as a model of reality.
265 Lehtonen J. From an undifferentiated cry towards a modulated signal.
266 Leppänen O et al. Oral imatinib mesylate (STI571/gleevec) improves the efficacy of local intravascular vascular endothelial growth factor-C gene transfer in reducing neointimal growth in hypercholesterolemic rabbits.
267 Leys D et al. Prevention.
268 Li X et al. Phosphorylated eukaryotic translation factor 4E is elevated in alzheimer brain.
269 Lintula H et al. The costs and effects of laparoscopic appendectomy in children.
270 Liu J et al. cAMP-dependent protein kinase activation inhibits proliferation and enhances apoptotic effect of tumor necrosis factor-alfa in NCI-H295R adrenocortical cells.
271 Liu J et al. DNA methylation affects cell proliferation, cortisol secretion and steroidogenic gene expression in human adrenocortical NCI-H295R cells.
272 Liu L et al. Longitudinal observation on CSF Abeta42 levels in young to middle-aged amyloid precursor protein/presenilin-1 doubly transgenic mice.
273 Liu Y et al. Acute ischemic stroke: Predictive value of 2D phase-contrast MR angiography-serial study with combined diffusion and perfusion MR imaging.
274 Lukasiuk K, Pitkänen A. Large-scale analysis of gene expression in epilepsy reseach: is synthesis alreasy possible?
275 Lupsakko T. Functional Visual and Hearing Impairment in a Population Aged 75 Years and Older in the City of Kuopio in Finland. Associations With Mood and Activities of Daily Living.
276 Lupsakko T et al. The non-use of hearing aids in people aged 75 years and over in the city of Kuopio in Finland.
277 Lähteinen S et al. Brain-derived neurotrophic factor signaling modifies hippocampal gene expression during epileptogenesis in transgenic mice.
278 Länsimies E. Häpeästä kunniaan - itsetyydytyksen medikalisaation synkkä historia.
279 Maaranen P et al. Somatoform dissociation and adverse childhood experiences in the general population.
280 Majak K, Pitkänen A. Do seizures cause irreversible cognitive damage? Evidence from animal studies.
281 Majak K et al. Projections from the amygdaloid complex to the piriform cortex: A PHA-L study in the rat.
282 Mann JI et al. Evidence-based nutritional approaches to treatment and prevention of diabetes mellitus.
283 Markkanen A et al. Apoptosis induced by ultraviolet radiation is enhanced by amplitude modulated radiofrequency radiation in mutant yeast cells.
284 Maron E et al. Reduced brain serotonin transporter binding in patients with panic disorder.
285 Maron E et al. SPECT imaging of serotonin transporter binding in patients with generalized anxiety disorder.
286 Martikainen J et al. Potential cost-effectiveness of a family based program in mild Alzheimer´s disease patients.
287 Martikainen T et al. Long-term results, late complications and quality of life in a series of adjustable gastric banding.
288 Martikainen T et al. Mahalaukun ohitus laihdutusleikkauksena. Alkuvaiheen kokemuksia Kuopiosta.
289 Martikainen TJ et al. Dobutamine compensates deleterious hemodynamic and metabolic effects of vasopressin in the splanchnic region in endotoxin shock.
290 Mattila K, Lääkäri -98 tutkimusryhmä. Lääkärit terveyden edistäjinä.
291 Mauriala T et al. Determination of long-chain fatty acid acyl-coenzyme A compounds using liquid chromatography-electrospray ionization tandem mass spectrometry.
292 Mayhew P et al. Discrimination between cases of hip fracture and controls is improved by hip structural analysis compared to areal bone mineral density. An ex vivo study of the femoral neck.
293 Meriranta P et al. Verenpainepotilas terveyskeskuksessa: hoitotulokset paranemassa.
294 Mervaala E. Ääreishermojen sairaudet: Potilaan tutkiminen.
295 Mervaala E. Hermojen pinne- ja kompressiotilat.
296 Mervaala E, Partanen J. Polyneuropatiat.
297 Mervaala E, Räsänen E. Aivot ja mieli.
298 Miettinen T et al. Whiplash injuries in Finland - the possibility of some sociodemographic and psychosocial factors to predict the outcome after one year .
299 Miettinen T et al. The possibility to use simple validated questionnaires to predict long-term health problems after whiplash injury.
300 Miettinen T et al. Whiplash injuries in Finland: the situation 3 years later.
301 Miettinen TA, Gylling H. Prospects of increasing nutritional phytosterol levels in plants.
302 Miettinen TA, Gylling H. Plant stanol and sterol esters in prevention of cardiovascular diseases.
303 Miettinen TA et al. Low synthesis and high absorption of cholesterol characterize type 1 diabetes.
304 Miettinen TA et al. Kolesterolin imeytyminen ja synteesi tyyppien 1 ja 2 diabeteksessa.
305 Minkeviciene R et al. Memantine improves spatial learning in a transgenic mouse model of Alzheimer´s disease.
306 Musialowicz T et al. Midlatency auditory-evoked potentials in the assessment of sedation in cardiac surgery patients.
307 Mustonen P et al. The surgical and oncological safety of immediate breast reconstruction.
308 Mustonen PK et al. The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer.
309 Mykkänen J et al. Integration models in health information systems: experiences from the PlugIT project.
310 Márky I et al. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non -Hodkin lymphoma without central nervous involvement. A 6-year population-based study from the Nordic Society of Pediatric Hematology and Oncology.
311 Mähönen AJ et al. Optimized self-excising Cre-expression cassette for mammalian cells.
312 Mähönen MS et al. Current smoking and the risk of non-fatal myocardial infarction in the WHO MONICA project populations.
313 Mähönen S et al. Oral anticoagulant treatment in children based on monitoring at home.
314 Mäkelä EA et al. Kudossiirteet ihmisten varaosina.
315 Mäkelä OT et al. Effect of radiosynovectomy with Holmium-166 ferric hydroxide macroaggregate on adult equine cartilage.
316 Mäntyselkä P et al. Effects of dementia on perceived daily pain in home-dwelling elderly people: a population-based study.
317 Mäntyselkä P et al. Terveyskeskus ja tk-lääkärin työ lääketieteen ensimmäisen vuosikurssin opiskelijan kokemana.
318 Määttä A-M et al. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase - ganciclovir gene therapy.
319 Nairismägi J et al. Progression of brain damage after status epilepticus and its association with epileptogenesis: a quantitative MRI study in a rat model of temporal lobe epilepy.
320 Niemelä M, Jääskeläinen J. Akuutti neurokirurgia.
321 Niemimaa M et al. Downin oireyhtymän seulonta alkuraskaudessa.
322 Nieminen HJ et al. Ultrasound attenuation in normal and spontaneously degenerated articular cartilage.
323 Nieminen MT et al. Prediction of biomechanical properties of articular cartilage with quantitative magnetic resonance imaging.
324 Niittykoski M et al. Electrophysiologic changes in the lateral and basal amygdaloid nuclei in temporal lobe epilepsy: an in vitro study in epileptic rats.
325 Niklason A et al. Development of diabetes is retarded by ACE inhibition in hypertensive patients--a subanalysis of the Captopril Prevention Project (CAPPP).
326 Niskanen L. Oraaliset diabeteslääkkeet - missä mennään?
327 Niskanen L et al. Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus .
328 Niskanen L et al. Inflammation, abdominal obesity, and smoking as predictors of hypertension.
329 Niskanen L et al. Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome.
330 Niskanen LK et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort .
331 Niskanen M et al. Resource use after subarachnoid hemorrhage: comparison between endovascular and surgical treatment.
332 Niskanen M et al. Anestesialääkärin ja -sairaanhoitajan välinen työnjako.
333 Nissi MJ et al. Proteoglycan and collagen sensitive MRI evaluation of normal and degenerated articular cartilage.
334 Nissinen A et al. Community control of hypertension - experiences from Finland.
335 Nissinen J et al. Effect of lamotrigine treatment on epileptogenesis: an experimental study in rat.
336 Nissinen MJ et al. Ileal pouch-anal anatomosis, conventional ileostomy and ileorectal anatomosis modify cholesterol metabolism.
337 Nunes S et al. Pressure-volume relationships in acute lung injury: methodological and clinical implications.
338 Nunes SR. Longitudinal Clinical Characterization of the Acute Respiratory Distress Syndrome (ARDS).
339 Nurmi A et al. Nuclear factor-kappaB contributes to infarction after permanent focal ischemia.
340 Nurmi A et al. Pyrrolidine dithiocarbamate inhibits translocation of nuclear factor kappa-B in neurons and protects against brain ischaemia with a wide therapeutic time window.
341 Nuutinen J et al. Validation of a new dielectric device to assess changes of tissue water in skin and subcutaneous fat.
342 Ojala R. Lääkehoito raskauden ja imetyksen aikana.
343 Ojala R et al. What services doctors and nurses expect from hospital pharmacy?
344 Ojala R et al. Mitä palveluja lääkärit ja hoitajat odottavat sairaala-apteekilta?
345 Oksala N et al. Heat shock preconditioning and eicosanoid pathways modulate caspase 3-like activity in superficially injured isolated guinea pig gastric mucosa.
346 Paavonen J, Heinonen S. Lääketieteen perusopetustaa uudistettu perusteellisesti - Onko tuloksena parempia vai huonompia lääkäreitä?
347 Pahkala R, Qvarnström M. Can temporomandibular dysfunction signs be predicted by early morphological or functional variables?
348 Pahkala RH, Heino JP. Effects of sagittal split ramus osteotomy on temporomandibular disorders in seventy-two patients.
349 Pajukanta P et al. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1).
350 Pajusto M et al. Human in vivo-activated CD45R0+ CD4+ T cells are susceptible to spontaneous apoptosis that can be inhibited by the chemokine CXCL12 and IL-2, -6, -7, and -15.
351 Papp A et al. The progression of burn depth in experimental burns: a histological and methodological study.
352 Parkkinen A et al. Physiotherapy for female stress urinary incontinence: individual therapy at the outpatient clinic versus home-based pelvic floor training: a 5-year follow-up study.
353 Partanen P et al. Työolosuhteet hoitotyössä vuonna 2004: sairaanhoitajakyselyn tuloksia.
354 Parviainen I et al. Results and costs of intensive care in a tertiary university hospital from 1996 - 2000.
355 Patovirta RL et al. The remediation of mold damaged school - a three-year follow-up study on teachers' health.
356 Pellikainen J. Activator Protein -2 in Breast Cancer.
357 Pellikainen J et al. Expression of HER2 and its association with AP-2 in breast cancer.
358 Pellikainen JM et al. Expression of matrix metalloproteinase (MMP)-2 and MMP-2 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
359 Pellinen R et al. Cancer cells as targets for lentivirus-mediated gene transfer and gene therapy.
360 Pennanen C et al. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD.
361 Pennanen C et al. Serum testosterone levels in males with Alzheimer´s disease.
362 Penttilä I. Glykoituneen hemoglobiinin määritykset, niiden laatu sekä analyysien tulevaisuudennäkymät Suomessa.
363 Penttilä I, toim. Kliiniset laboratoriotutkimukset.
364 Penttilä I. Esipuhe.
365 Penttilä I et al. Kliininen laboratoriotoiminta.
366 Penttilä I, Tapola H. Liitteet.
367 Penttilä I, Tiikkainen U. Glykoituneen hemoglobiinin määritykset, niiden laatu sekä analyysien tulevaisuudennäkymät Suomessa.
368 Penttinen M et al. Fabryn tauti ja suositus sen diagnostiikasta, seurannasta ja hoitolinjoista Suomessa.
369 Pesonen TM et al. Gender-related changes in suicide rates and methods in Eastern Finland from 1988 to 1997.
370 Petrova TV et al. Defective valves and abnormal mural cell recruitment underline lymphatic vascular failure in lymphedema distichiasis.
371 Peurala SH et al. How much exercise does the enhanced gait-oriented physiotherapy provide for chronic stroke patients?
372 Pietilä A-M, Vehviläinen-Julkunen K. Hoitotyön johtamista pohditaan terveystieteellisessä symposiumissa.
373 Pietilä J et al. Eight-year follow-up of photorefractive keratectomy for myopia.
374 Pihlajamäki J et al. Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men.
375 Pihlajamäki J et al. The Pro12Ala polymorphism of the PPARgamma2 gene regulates weight from birth to adulthood.
376 Pihlajamäki M. Functional MRI Studies on Human Declarative Memory.
377 Pihlajamäki M et al. Visual presentation of novel objects and new spatial arrangements of objects differentially activates the medial temporal lobe subareas in humans.
378 Piippo-Savolainen E et al. Asthma and lung function 20 years after wheezing in infancy. Results from a prospective follow-up study.
379 Pirinen E et al. Analysis of the human hexokinase II promoter in vivo: lack of insulin response within 4.0 kb.
380 Pirttilä T. Varhainen MS-tauti - diagnostinen haaste.
381 Pirttilä T. Taudin kulkua muunteleva hoito MS-taudissa.
382 Pirttilä T, Nybo T. Kipu ja kognitio.
383 Pirttilä T. Muistihäiriöisen ja dementoituvan henkilön kuntoutus: Muistihäiriöisen ja dementoituvan henkilön kuntoutuksen mahdollisuudet.
384 Pirttilä T. Mitä kaikkea minun pitäisi tietää dementiasta?
385 Pirttilä T. Dementia.
386 Pirttilä T et al. Voidaanko muistin heikentymistä ehkäistä?
387 Pirttilä T et al. Cerebrospinal fluid insulin-like growth factor-1, insulin growth factor binding protein-2 or nitric oxide are not increased in MS or ALS.
388 Pirttilä T et al. Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer´s disease: multicenter trial.
389 Pitkänen A. Denervation and reinnervation of amygdaloid neurons in drug-refratory temporal lobe epilepsy.
390 Pitkänen A. New pharmacotherapy for epilepsy.
391 Pitkänen A, Kubova H. Antiepileptic drugs in neuroprotections.
392 Pitkänen A et al. Atipamezole, an alfa2-adrenoceptor antagonist, has disease modifying effects on epileptogenesis in rats.
393 Pitkänen L et al. Neural retina limits the nonviral gene transfer to retinal pigment epithelium in an vitro bovine eye model.
394 Pitkänen P. Laboratoriotutkimusten ohjekirja 2004.
395 Porkkala-Sarataho E et al. Saattaa se sittenkin olla totta...HDL-kolesteroilin määritysmenetelmissä on suuria eroja.
396 Porkkala-Sarataho E et al. Kokoveren bilirubiinin määrittäminen Omni S6 - verikaasuanalysaattorilla.
397 Pukkila M. Prognostic Factors in Pharyngeal Squamous Cell Carcinoma With Special Reference to Cell Adhesion, p53 Protein Expression and Nitric Oxide Synthase Expression.
398 Pukkila MJ et al. Versican expression in pharyngeal squamous cell carcinoma: an immunohistochemical study.
399 Pulkkanen KJ et al. Cancer gene therapy - current status in the clinics.
400 Pullinen K et al. Hypotermisen potilaan elvytys - kahden potilaan hoidon kuvaus.
401 Puncuh F et al. Use of spinal anaesthesia in paediatric patients: a single centre experience with 1132 cases.
402 Punnonen K et al. D-dimeeripitoisuus syvän laskimotukoksen tai keuhkoembolian diagnostiikassa.
403 Puolakka K et al. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: A five-year randomized followup trial.
404 Purhonen M. Event-Related Potential (ERP) Studies of Mother-Infant Interaction.
405 Purhonen M et al. Cerebral processing of mother's voice compared to unfamiliar voice in 4-month-old infants.
406 Putkonen A et al. Comorbid personality disorders and substance use disorders of mentally I11 homide offenders: A structural clinical study on dual and triple diagnoses.
407 Puurunen K et al. Neuroprotection by the alfa2-adrenoceptor agonist, dexmedetomidine, in experimental stroke models.
408 Puustjärvi T et al. Plasma and aqueous humour levels of homocysteine in exfoliation syndrome.
409 Pyörälä K et al. Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I and II surveys.
410 Pölkki T et al. Hoitotieteellisen interventiotutkimuksen käytännöllisiä ratkaisuja - esimerkkinä lasten postoperatiivisen kivun hoidon tutkimus.
411 Pölkki T et al. Vanhempien näkemyksiä osallistumisestaan lapsen kivunhoitoon sairaalassa.
412 Pöyhönen M et al. The effect of carbon dioxide, respiratory rate and tidal volume on human heart rate variability.
413 Raitanen T et al. Geropsykologia. Vanhenemisen ja vanhuuden psykologia.
414 Randell K. Effects of Hormonal and Others Factors on Fractures in Peri- and EEarly Postmenopausal Women.
415 Rankinen T et al. The human gene map for performance and health-related fitness phenotypes: The 2003 update.
416 Rantanen T et al. Psoriaasin uudet hoidot - yhdistelmävoidetta ja biologisia lääkkeitä.
417 Rastas S et al. Association of apolipoprotein E genotypes, blood pressure, blood lipids and ECG abnormalities in a general population aged 85+.
418 Rauramaa R et al. Effects of aerobic physical exercise on inflammation and atherosclerosis in Men: The DNASCO study. A six-year randomized, controlled trial.
419 Rauramaa R et al. In response [Aerobic physical exercise and atherosclerosis in men].
420 Rautiala S et al. Potentially pathogenic, slow-growing mycobacteria released into workplace air during the remediation of buildings.
421 Reinikainen M et al. Reply (to Cardiac arrest after interscalene brachial plexus block).
422 Remes T et al. The association of bone metabolism with bone mineral density, serum sex hormone concentrations, and regular exercise in middle-aged men.
423 Riekki R et al. The production of collagen and the activity of mast-cell chymase increase in human skin after irridation therapy.
424 Rieppo J et al. Reference sample method reduces the error caused by variable cryosection thickness in Fourier transform infrared imaging.
425 Riikonen R. Infantile spasms: Therapy and outcome.
426 Riikonen R et al. Cerebrospinal fluid insulin-like growth factor (IGF-1) and insulin-like growth factor binding protein (IGFBP-2) in children with acute lymphoblastic leukemia.
427 Rilla K et al. The hyaluronan synthesis inhibitor 4-methylumbelliferone prevents keratinocyte activation and epidermal hyperproliferation induced by epidermal growth factor.
428 Rinne JO et al. Striatal dopaminergic system in dopa-responsive dystonia: a multi-tracer PET study shows increased D2 receptors.
429 Rioux JD et al. Genomewide search and association studies in a Finnish celiac disease population: identification of a novel locus and replication of HLA and CTLA4 loci.
430 Rissanen TT et al. Gene transfer for therapeutic vascular growth in myocardial and peripheral ischemia.
431 Ristikankare M et al. Is routine sedation or topical pharyngeal anesthesia beneficial during upper endoscopy?
432 Ritvanen T et al. Relief of work stress after weekend and holiday season in high school teachers.
433 Ronkainen A, Hernesniemi J. Familial vascular diseases of neurosurgical significance.
434 Ropponen KM, Alafuzoff I. Reply to Prof. J.J. Kepes (Castleman's disease of the leptomeninges).
435 Ruoppi P. Allergisen nuhapotilaan tutkiminen ja hoito.
436 Ruoppi P. Allerginen nuha.
437 Ruoppi P. Nenän irtosolututkimus.
438 Ruoppi P. Atrofinen nuha ja hajunenä (otseena).
439 Ruoppi P. Kosteusvauriorakennuksiin liittyvä nuha.
440 Ruoppi P. Nenäpolyypit.
441 Ruoppi P et al. Frequency of allergic rhinitis to laboratory animals in university employees as confirmed by chamber challenges.
442 Ruoppi P et al. A rapidly progressing periorbital mass in an infant: Fasciitis nodularis.
443 Ruponen M et al. Cell-surface glycosaminoglycans inhibit cation-mediated gene transfer.
444 Rutanen J et al. The Val103Ile polymorphism of melanocortin-4 receptor regulates energy expenditure and weight gain.
445 Rutanen J et al. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart.
446 Rutanen J et al. Transmyocardial angiogenic effects after intramyocardial adenoviral catheter-mediated VEGF-A and VEGF-D gene transfer in the porcine heart.
447 Ruutu T et al. Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycle.
448 Räty JK et al. Enhanced gene delivery by avidin-displaying baculovirus.
449 Saarakkala S et al. Mechano-acoustic determination of Young's moduls of articular cartilage.
450 Saarakkala S et al. Ultrasonic quantitation of superficial degradation of articular cartilage.
451 Saarelainen S et al. Assessment of recombinant dog allergens Can f 1 and Can f 2 for the diagnosis of dog allergy.
452 Saarikoski S. Raskauden keston häiriöt.
453 Saarinen P et al. Psykodynaamisesti suuntautunut psykoterapia masennuspotilaiden kuntoutuksessa.
454 Saaristo A et al. Vascular endothelial growth factor-C gene therapy restores lymphatic flow across incision wounds.
455 Salmenniemi U et al. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome.
456 Salonvaara M. Coagulation Physiology and Abnormalities in Newborn Infants. Association with Intraventricular Haemorrhage and Central Venous Cather-related Thrombosis.
457 Salonvaara M et al. Diagnosis and treatment of a newborn with homozygous protein C deficiency.
458 Salonvaara M et al. Development of selected coagulation factors and anticoagulants in preterm infants by the age of six months.
459 Salopuro T et al. Common variants in beta2- and beta3-adrenergic receptor genes and uncoupling protein 1 as predictors of the risk for type 2 diabetes and body weight changes. The Finnish diabetes prevention study .
460 Schwab U, Gylling H. K-vitamiinin tasainen saanti on tärkeää varfariinihoidon aikana.
461 Schönberg-Norio D et al. Swimming and Campylobacter infections.
462 Setälä LP et al. Glucose, lactate, and pyruvate response in an experimental model of microvascular flap ischemia and reperfusion: a microdialysis study.
463 Siitonen N et al. Association between a deletion/insertion polymorphism in the alfa2B-adrenergic receptor gene and insulin secretion and type 2 diabetes. The Finnish diabetes prevention study.
464 Sillanpää P et al. Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk.
465 Silvennoinen A et al. Kuntoutuminen masennusta sairastavilla kuntoutustutkimusasiakkailla.
466 Sirola J et al. Factors related to postmenopausal muscle performance: a cross-sectional population-based study.
467 Sivenius J, Jolkkonen J. Uutta näyttöä aivohalvauskuntoutuksen vaikutuksista.
468 Sivenius J et al. Continuous 15-year decrease in incidence and mortality of stroke in Finland. The FINSTROKE Study.
469 Sivenius J et al. FINSTROKE-tutkimus: Aivohalvauksen ilmaantuvuus ja kuolleisuus laskivat Suomessa vuosina 1983-1997.
470 Sivenius K. Genetic Studies on Type 2 Diabetes Mellitus with Special Emphasis on Obesity and Microvascular Complications.
471 Sivenius K et al. Aldose reductase gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes.
472 Sivenius K et al. Aldose reductase gene polymorphisms and peripheral nerve function in patients with type 2 diabetes.
473 Skari H et al. Congenital diaphragmatic hernia: a survey of practice in Scandinavia.
474 Soderstrom H et al. A controlled study of tryptophan and cortisol in violent offenders.
475 Sohlberg A. Molecular Small Animal Imaging With Pinhole Single-Photon Emission Computed Tomography.
476 Sohlberg A et al. Mitä isotooppikuvantaminen on?
477 Sohlberg A et al. Improving the quality of small animal brain pinhole SPECT imaging by Bayesian reconstruction.
478 Soini I et al. Magnetic resonance imaging of the rotator cuff in destroyed rheumatoid shoulder: comparison with findings during shoulder replacement.
479 Soininvaara TA et al. Bone mineral density in the proximal femur and contralateral knee after total knee arthroplasty.
480 Soininvaara TA et al. Periprosthetic femoral bone loss after total knee arhtroplasty: 1-year follow-up study of 69 patients.
481 Soininvaara TA et al. Periprosthetic tibial bone mineral density changes after total knee arthroplasty.
482 Soinio M et al. Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus.
483 Sourander A et al. Mental health service use among 18-year-old adolescent boys: a prospective 10-year follow-up study.
484 Suomalainen L et al. Activator protein-1 in human male germ cell apoptosis.
485 Suomen Kardiologisen Seuran asettama työryhmä. Syvä laskimotukos ja keuhkoembolia.
486 Suomen Kehitysvammalääkärit ry:n asettama työryhmä. Downin oireyhtymään liittyvien lääketieteellisten ongelmien hyvä hoito. Käypä hoito -suositus.
487 Suomen Ortopediyhdistys ry:n asettama työryhmä. Aikuispotilaan säärimurtuman hoito.
488 Suomen Sisätautilääkärien Yhdistys ry:n asettama työryhmä. Dyslipidemiat.
489 Suuriniemi M et al. Association between exercise and pubertal BMD is modulated by estrogen receptor alfa genotype.
490 Suwiwat S et al. Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer.
491 Syväoja S, Niskanen M. Anestesialaatutietokanta keskus- ja yliopistosairaalan näkökulmasta.
492 Tahvanainen K et al. Cellular phone use does not acutely affect blood pressure or heart rate of humans.
493 Taipale P et al. Cloacal anomaly simulating megalocystis in the first trimester.
494 Taipale P et al. Prenatal diagnosis of placenta accreta and percreta with ultarasonography, color doppler and magnetic resonance imaging.
495 Takkunen O. Kuulumisia Kuopiosta.
496 Tanskanen A et al. Impact of multiple traumatic experiences on the persistence of depressive symptoms- a population-based study.
497 Tanskanen A, Tiihonen J. Omega-3-rasvahapot -uusi lisähoito masennukseen?
498 Tapola NS et al. Mineral water fortified with folic acid, vitamins B6, B12, D and calcium improves folate status and decreases plasma homocysteine concentration in men and women.
499 Tapola NS et al. The effect of meat products enriched with plant sterols and minerals on serum lipids and blood pressure.
500 Temelkova-Kurktschiev T et al. Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis.
501 Teriete P et al. Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44.
502 Tervo AJ et al. An in silico approach to discovering novel inhibitors of human sirtuin type 2.
503 Tervo S et al. Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects.
504 Testa C et al. A comparison between the accurancy of voxel-based morphometry and hippocampal volumetry in Alzheimer`s disease.
505 The CHEK2 Breast Cancer Case-Control Consortium. CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies.
506 The DREAM Trial Investigators. Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial.
507 The FIELD Study Investigators. The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabets (FIELD) study. [ISRCTN64783481].
508 Tiihonen J et al. Brain serotonin 1A receptor binding in bulimia nervosa.
509 Tikanoja T, Taipale P. Ascites nuchal fold as the first signs of progressive cardiac diastolic dysfunction in a fetus with fetal growth restriction due to mulibrey nanism.
510 Timonen KL et al. Daily variation in fine and ultrafine particulate air pollution and urinary concentrations of lung Clara cell protein CC 16.
511 Todorova B et al. The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study.
512 Toivanen A et al. Polvinivelrikon kliininen ja radiologinen diagnoosi väestötutkimuksessa.
513 Toivonen S et al. Obstetric prognosis after placental abruption.
514 Toivonen S et al. Risk of placental abruption in first-degree relatives of index patients.
515 Toivonen S et al. Low-activity haplotype of the microsomal epoxide hydrolase gene is protective against placental abruption.
516 Tolmunen T et al. Dietary folate and the risk of depression in Finnish middle-aged men. A prospective follow-up study.
517 Tolmunen T et al. Association between depressive symptoms and serum concentrations of homocysteine in men: a population study.
518 Tolmunen T et al. Elevated midbrain serotonin transporter availability in mixed mania : a case report.
519 Torvinen E et al. Mycobacteria in water and loose deposits of drinking water distribution systems in Finland.
520 Tuhkanen H et al. Marked allelic imbalance on chromosome 5q31 does not explain a-catenin expression in epithelial ovarian cancer.
521 Tuhkanen H et al. Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p.
522 Tuhkanen K. Contact and Hybrid Laser in the Treatment of Benign Prostatic Hyperplasia.
523 Tuhkanen K et al. Sexual function of LUTS patients before and after neodymium laser prostatectomy and transurethral resection of prostate.
524 Tuomainen R. Biotekniikan ja medikalisaation vaikutukset ihmiskuvaamme.
525 Tuomainen R et al. Monipuolinen arviointi on tarpeen sairaanhoitopiirin kehittämistyössä.
526 Tuomainen R, Saarikoski S. Kokemukset synnytysten keskittämisestä onnistuneita.
527 Tuomisto TT et al. HIF-VEGF-VEGFR-2, TNF-alfa and IGF pathways are upregulated in critical human skeletal muscle ischemia as studied with DNA array.
528 Tuovinen L et al. Starch acetate microparticles for drug delivery into retinal pigment epithelium - in vitro study.
529 Tuovinen T. Sementoinnin haitat.
530 Tupala E et al. Cortical dopamine D2 receptors in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography.
531 Tupala E, Tiihonen J. Dopamine and alcoholism: neurobiological basis of ethanol abuse.
532 Tupola S et al. Comparison of regional cerebral perfusion, EEG and cognitive functions in type 1 diabetic children with and without severe hypoglycaemia.
533 Tuppurainen M et al. The combined contraceptive vaginal ring (NuvaRing) and lipid metabolism: a comparative study.
534 Tuppurainen M, Komulainen M. Osteoporoosi.
535 Turunen JHO et al. How do people ease their pain? A population-based study.
536 Turunen P et al. Adenovirus-mediated gene transfer of Lp-PLA2 reduces LDL degradation and foam cell formation in vitro.
537 Turunen V et al. Työikäisten potilaiden lonkan tekonivelleikkausten sairaalahoito- ja päivärahakustannukset.
538 Turunen V et al. Polven nivelrikko työikäisillä.
539 Törrönen Riitta, Gylling H, eds. The 20th Anniversary Symposium of the Department of Clinical Nutrition. March 18-19, 2004 Kuopio, Finland. Abstracts.
540 Uusaro A. Alkoholinkäytön yhteys tehohoidon tarpeeseen, resursien käyttöön ja tuloksiin.
541 Uusimaa P et al. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension.
542 Uusitalo AL et al. Physical training and heart rate and blood pressure variability - a five year randomized trial.
543 Uusitalo ALT et al. Abnormal serotonin reuptake in an overtrained, insomnic and depressed team athlete.
544 Uusitalo H. Biomateriaalien silmäsovellukset.
545 Uusitupa M. Perinnöllisen kombinoituneen hyperlipidemian (FKH) geneettinen tausta - rengas kiristyy.
546 Uusitupa M. Ravitsemus- ja liikuntasuositukset linjaavat tervytemme perustan.
547 Uusitupa M et al. Elämäntapamuutokset korjaavat pysyvästi insuliiniresistenssia heikentyneessä sokerinsiedossa.
548 Vaajoki A et al. Aikuisten nivelreumakipu - kärsimyksen vai hyvinvoinnin tunteita?
549 Vaccaro O et al. Comparative evaluation of simple indices of insulin resistance.
550 Valkeinen H et al. Changes in knee extension and flexion force, EMG and functional capacity during strength training in older females with fibromyalgia and healthy controls.
551 Valkonen-Korhonen M, Lehtonen J. Mitä jokaiselle lääkärille pitäisi opettaa psykiatriasta.
552 Vallittu P, Forss H. Uudet materiaalit hammaslääketieteen mullistajana.
553 Valonen PK et al. Water diffusion in a rat glioma during ganciclovir-thymidine kinase gene therapy-induced programmed cell death in vivo: Correlation with cell density.
554 Valpas A et al. Tension-free vaginal tape and laparoscopic mesh colposuspension for stress urinary incintinence.
555 Valtonen H et al. Patient contact with healthcare professionals after elective tonsillectomy.
556 Valtonen J et al. Keuhkopussin paikallinen sidekudoskasvain.
557 van der Voet M et al. Intracranial aneurysms in Finnish families: confirmation of likage and refinement of the intrval to chromosome 19q13.3.
558 van Groen T et al. Retrosplenial cortex lesions of area Rgb (but not of area Rga) impair spatial learning and memory in the rat.
559 Vanamo K et al. The Santulli enterostomy in necrotising enterocolitis.
560 Vapalahti M. Comments (to Incidence and early prognosis of aneurysmal subarachnoid hemorrhage in Kumamoto prefecture, Japan).
561 Vapalahti M. Comments (to Anxiety and depression after spontaneous surarachnoid hemorrhage).
562 Varpula T et al. Airway pressure release ventilation as a primary ventilatory mode in acute respiratory distress syndrome.
563 Vasara AI et al. Subchondral bone reaction associated with chondral defect and attempted cartilage repair in goats.
564 Vehviläinen A et al. Työikäisten sepelvaltimotautipotilaiden hoidon kokonaiskustannukset.
565 Vehviläinen-Julkunen K, Pietilä A-M. Tutkimus Kuopion yliopiston hoitotieteen laitoksella: tavoitteena yhteiskunnallinen vaikuttaminen.
566 Vehviläinen-Julkunen K, Pietilä A-M, toim. Miten arvioida ja hoitaa potilaiden moniulotteista kipua? Otteita kokemuksista, menetelmistä ja etiikasta.
567 Vehviläinen-Julkunen K, Pietilä A-M. Hoitotieteen tutkimusta 25 vuotta Kuopion yliopistossa - tutkimuksen painopisteiden vahvistamista.
568 Vehviläinen-Julkunen K, Pietilä A-M. Hoitotieteellinen tutkimus kivun hoidon perustana.
569 Venesmaa P. Periprosthetic Femoral Bone Loss and Bone Turnover after Primary Total Hip Arthrosplasty.
570 Vercauteren FGG et al. Early dysregulation of hippocampal proteins in transgenic rats with Alzheimer's disease-linked mutations in amyloid precursor protein and presenilin 1.
571 Viinamäki H et al. Is the Beck Depression Inventory suitable for screening major depression in different phases of the disease?
572 Virjo I et al. "Herättää kollegoissa aito halu oppia jatkuvasti uutta" - Lääkärien mielipiteitä täydennyskoulutuksesta.
573 Virtanen T et al. Re: External carotid artery territory ischemia impairs outcome in the endovascular filament model of middle cerebral artery occlusion in rats.
574 Virtanen T, Mäntyjärvi R. Mammalian allergens.
575 Vornanen M et al. Maha-suolikanavan lymfoomat.
576 Voutilainen A et al. Theoretical analysis of the influence of aerosol size distribution and physical activity on particle deposition pattern in human lungs.
577 Vuorio AF et al. Hypolipidemic treatment of heterozygous familial hypercholesterolemia: a lifelong challenge.
578 Vähäkangas K, Länsimies E. Suostumuskäytäntö ja henkilöllisyyden suoja geenipankkitutkimuksissa.
579 Väisänen J et al. Effects of NMDA-receptor antagonist treatment on c-fos expression in rat brain areas implicated in schizophrenia.
580 Välimäki T et al. Coping abilities at home: rehabilitation in mild Alzheimer's disease [cd-rom].
581 Väänänen R, Hämäläinen J. Kokemuksia huostaanotosta ja huostaanotettujen lasten vanhempien tukitoiminnasta.
582 Walkowiak J, Herzig K-H. The authors' reply [to Vegetarian diet and exocrine pancreatic function using fecal tests].
583 Walkowiak J et al. Giardiasis aggravates malabsorption in cystic fibrosis.
584 Walkowiak J et al. Faecal elastase-1 test is superior to faecal lipase test in the assessment of exocrine pancreatic function in cystic fibrosis.
585 Walkowiak J et al. Serum lipase after secretin stimulation detects mild pancreatic involvement in cystic fibrosis.
586 Walkowiak J et al. Vegetarian diet alters the assessment of exocrine pancreatic function with the use of fecal tests.
587 Wilding J et al. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects.
588 Wilson IA et al. Cognitive aging and the hippocampus: How old rats represent new environments.
589 Yavich L et al. Role of alfa-synuclein in presynaptic dopamine recruitment .
590 Yazdanparast P et al. A thyroid hormone analogue, triiodothyroacetic acid, corrects corticosteroid-downregulated collagen synthesis.
591 Yli-Jokipii KM et al. Positional distribution of decanoic acid: Effect on chylomicron and VLDL tag structures and postprandial lipemia.
592 Yliharsila H et al. Interactions between peroxisome proliferator-activated receptor-gamma 2 gene polymorphisms and size at birth on blood pressure and the use of antihypertensive medication.
593 Ylinen J. Treatment of Chronic Non-Specific Neck Pain with Emphasis on Strength Training.
594 Ylinen J et al. Kaularangan ja hartialihasten harjoittelu kroonisen niskakivun hoitona.
595 Ylinen J et al. Association of neck pain, disability and neck pain during maximal effort with neck muscle strength and range of movement in women with chronic non-specific neck pain.
596 Ylä-Herttuala S. Therapeutic angiogenesis.
597 Ylä-Herttuala S. Viral vs. non-viral vectors for myocardial angiogenesis.
598 Ylä-Herttuala S, Dzau VJ. Introduction.
599 Ylä-Herttuala S et al. Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trials.
600 Yppärilä H. Depth of Sedation in Intensive Care Patients.
601 Yppärilä H et al. N100 auditory potential and electroencephalogram discriminate propofol-induced sedation levels.
602 Yppärilä H et al. The effect of interruption to propofol sedation on auditory event-related potentials and electroencephalogram in intensive care patients.
603 Zeniya T et al. A new reconstruction strategy for image improvement in pinhole SPECT.
604 Zeniya T et al. Image improvement in pinhole SPECT using complete data acquisition combined with statistical image reconstruction.
605 Zerres K et al. New options for prenatal diagnosis in autosomal recessive polycystic kidney disease by mutation analysis of the PKHD1 gene.
606 Zhang Z et al. Carotid artery stenosis: reproductibility of automated 3D CT angiography analysis method.
607 Öhman J, Jääskeläinen J. Hydrokefalus ja likvorivuoto.
608 Öhman J, Jääskeläinen J. Aivovammat.

Kuopion yliopistollinen sairaala Kuopio University Hospital
Julkaisutietokanta 25.10.2005 Publications Data Base 25.10.2005